SCHEMBL9998196

SCHEMBL9998196

CC(=O)OC(OC(C)=O)/C(C)=C/c1cccc(Br)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 1/20 0.45
SLC6A19 Q695T7 1/20 0.43
ALDH1A1 P00352 2/20 0.43
AKR1C3 P42330 1/20 0.42
AKR1C2 P52895 1/20 0.42
MAPT P10636 2/20 0.40
HTT P42858 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
PKM P14618 1/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
MAOB P27338 3/20 0.38
MAOA P21397 2/20 0.38
SLC9A1 P19634 1/20 0.38
SLC9A3 P48764 1/20 0.38
SLC9A2 Q9UBY0 1/20 0.38
CCR6 P51684 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
BACE1 P56817 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998197 1.00 HSD17B3 (0.45) HSD17B3SLC6A19ALDH1A1AKR1C3AKR1C2
SCHEMBL9997512 0.84 SLC6A19 (0.47) HSD17B3SLC6A19ALDH1A1AKR1C3AKR1C2
SCHEMBL9997286 0.84 SLC6A19 (0.47) HSD17B3SLC6A19ALDH1A1AKR1C3AKR1C2
SCHEMBL9997490 0.84 HSD17B3 (0.42) HSD17B3SLC6A19ALDH1A1AKR1C3AKR1C2
SCHEMBL9997245 0.83 LMNA (0.44) ALDH1A1MAPTPKMKMT2AMEN1
SCHEMBL9997246 0.83 LMNA (0.44) ALDH1A1MAPTPKMKMT2AMEN1
SCHEMBL9997568 0.82 SLC6A19 (0.45) HSD17B3SLC6A19ALDH1A1AKR1C3AKR1C2
SCHEMBL9997570 0.82 SLC6A19 (0.45) HSD17B3SLC6A19ALDH1A1AKR1C3AKR1C2
SCHEMBL9997583 0.82 PTGS1 (0.47) AKR1C3AKR1C2MAPTPKMNPC1
SCHEMBL9997580 0.82 PTGS1 (0.47) AKR1C3AKR1C2MAPTPKMNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 HSD17B3 454/4885SLC6A19 1360/4885ALDH1A1 160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.